Müller M J
Institut für Humanernährung und Lebensmittelkunde, Christian-Albrechts-Universität zu Kiel.
Z Gastroenterol. 1996 Jan;34(1):36-40.
During parenteral nutrition hepatic complications are seen in about 15% of patients. They are characterized by steatosis, cholestasis and formation of sludge and bile stones. These hepatic complications depend on the duration as well as on the concept and mode of application of parenteral nutrition. They are more frequent after treatment periods of > 1-2 weeks, in response to a carbohydrate rich and low fat parenteral nutrition and in patients with extensive intestinal resection. Clinically, hepatic complications are frequently observed in new-borns and children, patients with inflammatory bowel disease, after ileum resection and in patients with hepatic malignancies. The exact pathophysiology of these phenomena is presently unknown. Enteral instead of parenteral nutrition, meeting the demand of nutrients, increasing fat supply (up to 50% of energy supply), "cyclic" parenteral nutrition and the addition of "semi-essential" nutrients (like L-glutamine, carnitin, cholin) are considered as possible strategies for the prevention and therapy of hepatic complications during parenteral nutrition.
接受肠外营养的患者中,约15%会出现肝脏并发症。其特征为脂肪变性、胆汁淤积以及胆泥和胆结石形成。这些肝脏并发症取决于肠外营养的持续时间以及应用理念和方式。在治疗时间超过1 - 2周后、给予富含碳水化合物且低脂的肠外营养时以及广泛肠道切除的患者中,并发症更为常见。临床上,肝脏并发症在新生儿和儿童、炎症性肠病患者、回肠切除术后患者以及肝脏恶性肿瘤患者中较为常见。目前尚不清楚这些现象的确切病理生理学机制。采用肠内营养而非肠外营养、满足营养需求、增加脂肪供应(高达能量供应的50%)、“循环”肠外营养以及添加“半必需”营养素(如L - 谷氨酰胺、肉碱、胆碱)被认为是预防和治疗肠外营养期间肝脏并发症的可能策略。